000			02111cam a2200241 4500
008			030502s2003 xxu eng
020			_a0471227692
035			_a(Sirsi) i0471227692
060			_aQV 38 2003PH
700	1		_aRothstein, Mark A .
245	0	0	_aPharmacogenomics : _bsocial, ethical, and clinical dimensions / _cedited by Mark A. Rothstein.
260			_aHoboken, N.J. : _bWiley-Liss, _c2003.
300			_a368 p.
505			_aPublic attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung -- Pharmacogenomics:pharmacology and toxicology in the genomics era / Harvey W. Mohrenweiser -- The implications of population genetics for pharmacogenomics / Craig L.Hanis -- Genome research and minorities / Henry T. Greely -- Drug development strategies / Penelope K. Manasco and Teresa E. Arledge -- Drug development, regulation, and genetically guided therapy / David W. Feigal and Steven I. Gutman -- Intellectual property and commercial aspects of pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and Gary A. Cohen -- Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky - - Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman -- Medical liability for pharmacogenomics -- Larry I. Palmer -- The challenges of pharmacogenomics for pharmacy education / David B. Brushwood -- Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson -- Pharmacogenomics and the social construction of identity / Morris W. Foster -- Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson -- Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson
650	0	2	_aPharmacogenetics.
650	0	2	_aDrug design
650	0	2	_aEthics, Medical.
650	0	2	_aLegislation, Medical.
650	0	2	_aPublic policy.
650	0	2	_aSocial environment.
596			_a4
942			_2NLM _cMONOGRAPH
999			_c26730 _d26730